IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

In the media

Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.
Media mentions
27 Nov 2019
Immunotherapy paves the way beyond cancer
Erika Lopez, IRB Barcelona.
Media mentions
25 Nov 2019
Understanding the effects of chemotherapy
Researchers at IRB Barcelona have identified these genetic footprints produced by some cancer treatments and have for the first time been able to calculate the genetic toxicity of some of these treatments. Claudia Arnedo, IRB Barcelona.
Media mentions
25 Nov 2019
The DNA damage caused by “chemo”
Predictive decision trees optimized to decide if a cancer mutation will become visible to the immune system. Rik G.H. Lindeboom, Radboud University.
Media mentions
25 Nov 2019
A new algorithm identifies the patients that will most benefit from immunotherapy
Salvador Aznar Beniath, IRB Barcelona
Media mentions
15 Nov 2019
Salvador Aznar Benitah receives the “Premio Fundación Carmen y Severo Ochoa 2019”
Carme Cortina, researcher at IRB Barcelona
Media mentions
7 Nov 2019
Five days at the Barcelona Science Park
Carme Cortina, postdoctoral fellow in the Colorectal Cancer Lab at IRB Barcelona.
Media mentions
30 Oct 2019
A new technique boosts current gene editing beyond expectations
Toni Gabaldón, ICREA researcher at IRB Barcelona and the BSC-CNS.
Media mentions
21 Oct 2019
Toni Gabaldón: "The true hope is that genomics emerges as a therapeutic tool"
The researcher Meritxell Teixidó has been interviewed on the TVE2’s documentary ¡Qué animal!
Media mentions
15 Oct 2019
Peptides in bee and scorpion venoms for drug delivery to the brain